MK0686 in Postsurgery Dental Pain (0686-002)

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00533403

Enrollment

114

Registered

2007-09-21

Start date

2004-07-31

Completion date

2004-11-30

Last updated

2015-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Postoperative

Brief summary

To compare the pain relieving effect of MK0686 to placebo or ibuprofen after dental surgery.

Interventions

DRUGMK0686

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE

Eligibility

Sex/Gender

ALL

Age

18 Years to 45 Years

Healthy volunteers

Inclusion criteria

* Men and women ages 18-45 years who are scheduled to have 2 or more third molars (wisdom teeth) removed * Patients must agree to remain in the clinic for 24 hours after surgery

Exclusion criteria

* Patient has history of heart disease, asthma, pulmonary disease * Patient must discontinue use of certain pain medicines 24-72 hours prior to the surgery

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026